Retatrutide, from Soma Pharmaceuticals , is attracting increasing attention as a novel treatment for weight management . This unique medication integrates the activity of a GLP-1 receptor activator and a GIP receptor stimulant, intended to not only promote weight loss but also improve associated metabolic issues . Early patient trials have shown ch